• Mashup Score: 0

    The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and other thoracic malignancies.

    Tweet Tweets with this article
    • It's time to get informed and inspired! #Immunotherapy researchers, clinicians & students are invited to attend #IO23. Explore the latest critical breakthroughs and learn from keynote Dr. Drew Pardoll of @BloombergKimmel. Don't miss it! Register: https://t.co/Hi9hCIX3DE #LCSM https://t.co/MNiXXaqdAO

  • Mashup Score: 3

    The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and other thoracic malignancies.

    Tweet Tweets with this article
    • Abstract Submission Extension #IO23! Submit your Abstract by 8/18 to showcase your research & contribute to discussions that will shape treatments in #lungcancer. Gain international visibility while networking & collaborating with colleagues. Submit Now: https://t.co/Hi9hCIXBtc https://t.co/L8RpEgJVJq

  • Mashup Score: 0

    The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and other thoracic malignancies.

    Tweet Tweets with this article
    • The #IO23 Meeting Co-Chairs invite you to attend this exciting event Nov. 10-12, 2023. With Keynote Speakers, opportunity for discussion/networking, & Poster Session. Educational sessions topic areas were recently announced! Learn More & Register: https://t.co/Hi9hCIX3DE #LCSM https://t.co/vG5Km8VgHx

  • Mashup Score: 0

    The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and other thoracic malignancies.

    Tweet Tweets with this article
    • We invite you to be a part of the groundbreaking #IO23 by submitting your abstract! Our conference focuses on the latest advancements & challenges in understanding & overcoming resistance to immune checkpoint inhibitors in #NSCLC. Submit Yours Today: https://t.co/OXVcckgrUB #LCSM https://t.co/DG1zM8aFAO